Recent insights in primary sclerosing cholangitis

被引:8
作者
Ponsioen, Cyriel Y. [1 ]
机构
[1] Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1100 DE Amsterdam, Netherlands
关键词
endoscopy; novel medical therapy; primary sclerosing cholangitis; DOSE URSODEOXYCHOLIC ACID; INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; NATURAL-HISTORY; NORURSODEOXYCHOLIC ACID; LIVER-TRANSPLANTATION; ENDOSCOPIC THERAPY; DUCT STRICTURES; PREVALENCE; RISK;
D O I
10.1111/j.1751-2980.2012.00605.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Primary sclerosing cholangitis (PSC) is a chronic inflammatory disease of the biliary tract leading to progressive obstruction, fibrosis and eventually liver cirrhosis. In some countries it ranks among the most frequent indications for liver transplantation. PSC is also a carcinogenic condition in which the risk of hepatobiliary carcinoma, especially cholangiocarcinoma, is greatly increased. Patients with associated inflammatory bowel disease involving the colon run an increased risk of colorectal carcinoma. Currently, there is no medical therapy with a proven benefit in halting disease progression.
引用
收藏
页码:337 / 341
页数:5
相关论文
共 44 条
[1]  
ABUELMAGD KM, 1993, TRANSPLANT P, V25, P1124
[2]   A Re-Evaluation of the Risk Factors for the Recurrence of Primary Sclerosing Cholangitis in Liver Allografts [J].
Alabraba, Edward ;
Nightingale, Peter ;
Gunson, Bridget ;
Hubscher, Stefan ;
Olliff, Simon ;
Mirza, Darius ;
Neuberger, James .
LIVER TRANSPLANTATION, 2009, 15 (03) :330-340
[3]   Clinical profile of primary sclerosing cholangitis in Singapore [J].
Ang, TL ;
Fock, KM ;
Ng, TM ;
Teo, EK ;
Chua, TS ;
Tan, JYL .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2002, 17 (08) :908-913
[4]  
[Anonymous], 2003, COCHRANE DB SYST REV
[5]   Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis [J].
Baluyut, AR ;
Sherman, S ;
Lehman, GA ;
Hoen, H ;
Chalasani, N .
GASTROINTESTINAL ENDOSCOPY, 2001, 53 (03) :308-312
[6]   Hepatic and extrahepatic malignancies in primary sclerosing cholangitis [J].
Bergquist, A ;
Ekbom, A ;
Olsson, R ;
Kornfeldt, D ;
Lööf, L ;
Danielsson, Å ;
Hultcrantz, R ;
Lindgren, S ;
Prytz, H ;
Sandberg-Gertzén, H ;
Almer, S ;
Granath, F ;
Broomé, U .
JOURNAL OF HEPATOLOGY, 2002, 36 (03) :321-327
[7]  
Bernstein CN, 2001, AM J GASTROENTEROL, V96, P1116
[8]   Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease [J].
Boonstra, Kirsten ;
van Erpecum, Karel J. ;
van Nieuwkerk, Karin M. J. ;
Drenth, Joost P. H. ;
Poen, Alexander C. ;
Witteman, Ben J. M. ;
Tuynman, Hans A. R. E. ;
Beuers, Ulrich ;
Ponsioen, Cyriel Y. .
INFLAMMATORY BOWEL DISEASES, 2012, 18 (12) :2270-2276
[9]   Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review [J].
Boonstra, Kirsten ;
Beuers, Ulrich ;
Ponsioen, Cyriel Y. .
JOURNAL OF HEPATOLOGY, 2012, 56 (05) :1181-1188
[10]   Risk and natural history of colonic neoplasia in patients with primacy sclerosing cholangitis and ulcerative colitis [J].
Brentnall, TA ;
Haggitt, RC ;
Rabinovitch, PS ;
Kimmey, MB ;
Bronner, MP ;
Levine, DS ;
Kowdley, KV ;
Stevens, AC ;
Crispin, DA ;
Emond, M ;
Rubin, CE .
GASTROENTEROLOGY, 1996, 110 (02) :331-338